Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63. (Record no. 26492307)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01541 a2200433 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517120804.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201802s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1949-2553 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.18632/oncotarget.12433 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ozaki, Toshinori |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180221 |
245 00 - TITLE STATEMENT | |
Title | Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Oncotarget |
Date of publication, distribution, etc. | Nov 2016 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 71937-71950 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antimetabolites, Antineoplastic |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Apoptosis |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Cycle Checkpoints |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Core Binding Factor Alpha 1 Subunit |
General subdivision | physiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Deoxycytidine |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Neoplasm |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genes, p53 |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Membrane Proteins |
General subdivision | physiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pancreatic Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gemcitabine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nakamura, Mizuyo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ogata, Takehiro |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sang, Meijie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yoda, Hiroyuki |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hiraoka, Kiriko |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sang, Meixiang |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shimozato, Osamu |
773 0# - HOST ITEM ENTRY | |
Title | Oncotarget |
Related parts | vol. 7 |
-- | no. 44 |
-- | p. 71937-71950 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.18632/oncotarget.12433">https://doi.org/10.18632/oncotarget.12433</a> |
Public note | Available from publisher's website |
No items available.